期刊文献+

抑制EphA7基因对肝癌细胞SMMC-7721裸鼠移植瘤血管生成的影响 被引量:1

Effects of silencing EphA7 gene on angiogenesis of SMMC-7721 cell xenograft in nude mice
原文传递
导出
摘要 目的 采用RNA干扰(RNAi)技术观察EphA7基因抑制对肝癌细胞SMMC-7721裸鼠移植瘤组织中血管生成的影响.方法 EphA7基因特异性小干扰RNA (siRNA)重组质粒采用脂质体介导法转染肝癌细胞SMMC-7721.裸鼠移植瘤模型采用左上肢皮下注射的方法建立,根据注射细胞的不同分为转染组、空载体转染组和未转染组.35 d后获取移植瘤组织,采用实时荧光定量聚合酶链反应(Real-time PCR)检测各组移植瘤组织中EphA7 mRNA的表达,免疫组织化学和蛋白印迹(Western blot)法检测各组裸鼠移植瘤组织中血管内皮生长因子(VEGF)和血管生成素-2(Ang-2)的蛋白表达并计算微血管密度(MVD).结果 Real-time PCR结果显示,与空载体转染组(0.390 0±0.086 3)和未转染组(0.421 9±0.0595)比较,转染组裸鼠移植瘤中EphA7 mRNA (0.191 1±0.020 4)的表达明显受到抑制,差异有统计学意义(P<0.05).免疫组织化学和Western blot结果显示,转染组裸鼠移植瘤组织中VEGF和Ang-2阳性染色的细胞明显较少且染色较浅,其蛋白的表达(0.360 9±0.075 2、0.334 7±0.088 2)明显低于空载体转染组(0.490 8±0.084 4、0.510 8±0.1048)和未转染组(0.555 9±0.075 4、0.5640±0.178 7),差异有统计学意义(P<0.05).微血管密度计算显示,转染组MVD平均值为42.88±12.80,明显低于空载体转染组(60.63±12.13)和未转染组(64.38±10.51),差异有统计学意义(P<0.05).结论 抑制EphA7基因能下调肝癌细胞SMMC-7721裸鼠移植瘤中VEGF和Ang-2的表达,EphA7基因可能通过调节VEGF和Ang-2的表达实现对肝癌细胞血管生成的调控. Objective To investigate the effects of RNA interference targeting EphA7 gene on angiogenesis of SMMC-7721 cell xenograft in nude mice.Methods Recombinant plasmid of EphA7 gene-targeting small interfering RNA (siRNA) was transfected into SMMC-7721 cells by LipofectamineTM 2000.The nude mice tumor model was established by subcutaneous injection of hepatic cancer cells in the left upper limb of the mice.The nude nice were then divided into transfected group,empty vector transfected group and untransfected group according to the different cells injected.The xenograft tumor tissues were obtained 35 days later.Real-time PCR assay was used to detect the expression of EphA7 mRNA in tumor tissues in different groups.Immunohistochemistry and Western blot assay were used to detect the expression of vascular endothelial growth factor (VEGF) and Angiopoietin-2 (Ang-2) protein in tumor tissues of different groups and the microvessel density (MVD) was calculated also.Results Real-time PCR results showed that compared with empty vector transfected group (0.390 0 ± 0.086 3) and untransfected group (0.421 9 ± 0.059 5),the expression of EphA7 mRNA in transfected group (0.191 1 ±0.020 4) was remarkably suppressed.Immunohistochemistry showed that VEGF and Ang-2 protein positive staining cells in tumor tissues of transfected group were less and lighter staining.Western blot assay showed that compared with empty vector transfected group (0.490 8 ± 0.084 4,0.510 8 ± 0.104 8) and untransfected group (0.555 9 ±0.075 4,0.564 0 ±0.178 7),the expression VEGF and Ang-2 protein in transfected group (0.360 9 ± 0.075 2,0.334 7 ± 0.088 2) were remarkably suppressed (P < 0.05).Microvessel density calculation shows that the average value of MVD of the transfected group (42.88 ± 12.80) was significantly lower than that of empty vector transfected group (60.63 ± 12.13) and untransfected group (64.38 ±10.51) (P<0.05).Conclusion The inhibition of EphA7 gene can down regulate the expression of VEGF and Ang-2 in SMMC-7721 hepatoma cell line.EphA7 may regulate angiogenesis of hepatocellular carcinoma through a regulation of the expression of VEGF and Ang-2.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第6期1313-1316,共4页 Chinese Journal of Experimental Surgery
基金 河南省科技厅重点科技攻关项目(092102310271) 河南省教育厅自然科学研究项目(2011A320060)
关键词 肝细胞肝癌 EPHA7 血管内皮生长因子 促血管生成素-2 血管生成 Hepatocellular carcinoma EphA7 Vascular endothelial growth factor Angiopoietin-2 Angiogenesis
  • 相关文献

参考文献13

  • 1Giaginis C, Tsoukalas N, Bournakis E, et al. Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung cmcino- ma:associations with clinieopathological parameters, tumor prolifera- tive capacity and patients' survival [ J ]. BMC Clin Pathol, 2014,14 (1):8.
  • 2Dawson DW, Hong JS, Shen RR, et al. Global DNA methylation profi- ling reveals silencing of a secreted form of EphA7 in mouse and hu- man germinal center B-cell lymphomas [ J ]. Oncogene, 2007, 26 (29) :4243-4252.
  • 3Wang LF, Fokas E, ]uricko J, et al. Increased expression of EphA7 correlales with adverse outcome in primary and recurrent glioblastoma multifomle patients [ J ]. BMC Cancer,2008,8 ( 1 ) :79.
  • 4Rigamonti N, Kadioglu E, Keklikoglou I, et al. Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade [ J ]. Cell Rep ,2014,8 (3) :696-306.
  • 5Bupathi M, Kaseb A,.lanku F. Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment : current perspectives [ J ]. Onco Targets Ther,2014,7 : 1927-1932.
  • 6张弓,李功权,吴阳,唐哲,赵永福,张水军.抑制Eph受体酪氨酸激酶A7基因对肝癌细胞SMMC-7721生物学特性的影响[J].中华实验外科杂志,2014,31(8):1712-1714. 被引量:2
  • 7时静祥,王毅军.肝癌的血管生成与VEGF—B[J].中华肝胆外科杂志,2010,16(4):317-320. 被引量:17
  • 8潘运龙,覃莉.白细胞介素-12抑制裸鼠肝癌Ang-2和血管内皮生长因子表达及其意义[J].中华实验外科杂志,2005,22(4):439-441. 被引量:10
  • 9Hafner C, Sehmitz G, Meyer S, et al. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers[J]. Clin Chem ,2004,50 ( 3 ) :490-499.
  • 10Liu DC, Yang ZL. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma [ J ]. Diagn Cytopathol, 2013,41 (3) :199-205.

二级参考文献47

  • 1龚时文,区庆嘉,闵军,陈涛,褚忠华.裸鼠肝部分切除术后肝癌血管内皮生长因子及微血管密度变化的研究[J].岭南现代临床外科,2003,3(1):53-54. 被引量:2
  • 2廖晓锋,易继林,张伟杰,李兴睿,邓巍,杨志芳,田耕.兔肝癌肝动脉栓塞后肿瘤血管生成的变化[J].中华实验外科杂志,2004,21(10):1173-1175. 被引量:9
  • 3文卫,杨连粤,黄耿文,杨治力,刘合利,杨建青.TSP-1和VEGF在肝细胞癌新生血管生成中的作用[J].中华肝胆外科杂志,2005,11(1):17-19. 被引量:19
  • 4Ciossek T, Millauer B, Ullrieh A. Identification of alternatively spliced mRNAs encoding variants of MDK1, a novel receptor tyrosine kinase expressed in the murine nervous system. Oncogene, 1995,10 : 97-108.
  • 5Hafner C, Schmitz G, Meyer S, et al. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem,2004,50 : 490-499.
  • 6Surawska H, Ma PC, Satgia R. The rote of Ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev,2004,15: 419- 433.
  • 7Brantley DM, Cheng N, Thompson EJ, et al. Soluble EphA receptors inhibit tumor angiogenesis and progression in vivo. Oncogene ,2002,21 : 7011-7026.
  • 8Wang LF, Fokas E, Juricko J, et al. Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multifonne patients. BMC Cancer, 2008,25 : 79.
  • 9Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature, 2000, 407 (6801) : 242-248.
  • 10Wang J, Kataoka H, Suzuki M, et al. Down regulation of EphA7 by hypermethylation in colorectal cancer. Oncogene, 2005,24 : 5637- 5647.

共引文献29

同被引文献13

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部